Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Cell ; 27(7): 1154-69, 2016 Apr 01.
Article in English | MEDLINE | ID: mdl-26842893

ABSTRACT

In mammals, histone H3.3 is a critical regulator of transcription state change and heritability at both euchromatin and heterochromatin. The H3.3-specific chaperone, DAXX, together with the chromatin-remodeling factor, ATRX, regulates H3.3 deposition and transcriptional silencing at repetitive DNA, including pericentromeres and telomeres. However, the events that precede H3.3 nucleosome incorporation have not been fully elucidated. We previously showed that the DAXX-ATRX-H3.3 pathway regulates a multi-copy array of an inducible transgene that can be visualized in single living cells. When this pathway is impaired, the array can be robustly activated. H3.3 is strongly recruited to the site during activation where it accumulates in a complex with transcribed sense and antisense RNA, which is distinct from the DNA/chromatin. This suggests that transcriptional events regulate H3.3 recruited to its incorporation sites. Here we report that the nucleolar RNA proteins Rpp29, fibrillarin, and RPL23a are also components of this H3.3/RNA complex. Rpp29 is a protein subunit of RNase P. Of the other subunits, POP1 and Rpp21 are similarly recruited suggesting that a variant of RNase P regulates H3.3 chromatin assembly. Rpp29 knockdown increases H3.3 chromatin incorporation, which suggests that Rpp29 represses H3.3 nucleosome deposition, a finding with implications for epigenetic regulation.


Subject(s)
Chromatin Assembly and Disassembly , Histones , Nucleosomes/metabolism , Ribonucleases , Ribonucleoproteins , Chromosomal Proteins, Non-Histone , Epigenesis, Genetic , Humans
2.
J Biol Chem ; 288(27): 19882-99, 2013 Jul 05.
Article in English | MEDLINE | ID: mdl-23689370

ABSTRACT

Unlike the core histones, which are incorporated into nucleosomes concomitant with DNA replication, histone H3.3 is synthesized throughout the cell cycle and utilized for replication-independent (RI) chromatin assembly. The RI incorporation of H3.3 into nucleosomes is highly conserved and occurs at both euchromatin and heterochromatin. However, neither the mechanism of H3.3 recruitment nor its essential function is well understood. Several different chaperones regulate H3.3 assembly at distinct sites. The H3.3 chaperone, Daxx, and the chromatin-remodeling factor, ATRX, are required for H3.3 incorporation and heterochromatic silencing at telomeres, pericentromeres, and the cytomegalovirus (CMV) promoter. By evaluating H3.3 dynamics at a CMV promoter-regulated transcription site in a genetic background in which RI chromatin assembly is blocked, we have been able to decipher the regulatory events upstream of RI nucleosomal deposition. We find that at the activated transcription site, H3.3 accumulates with sense and antisense RNA, suggesting that it is recruited through an RNA-mediated mechanism. Sense and antisense transcription also increases after H3.3 knockdown, suggesting that the RNA signal is amplified when chromatin assembly is blocked and attenuated by nucleosomal deposition. Additionally, we find that H3.3 is still recruited after Daxx knockdown, supporting a chaperone-independent recruitment mechanism. Sequences in the H3.3 N-terminal tail and αN helix mediate both its recruitment to RNA at the activated transcription site and its interaction with double-stranded RNA in vitro. Interestingly, the H3.3 gain-of-function pediatric glioblastoma mutations, G34R and K27M, differentially affect H3.3 affinity in these assays, suggesting that disruption of an RNA-mediated regulatory event could drive malignant transformation.


Subject(s)
Chromatin Assembly and Disassembly/physiology , Cytomegalovirus/metabolism , Histones/metabolism , Promoter Regions, Genetic/physiology , RNA, Viral/biosynthesis , Transcription, Genetic/physiology , Cell Line , Cytomegalovirus/genetics , Histones/genetics , Humans , Nucleosomes/genetics , Nucleosomes/metabolism , Protein Structure, Secondary , RNA, Viral/genetics
3.
PLoS One ; 5(4): e10272, 2010 Apr 21.
Article in English | MEDLINE | ID: mdl-20422051

ABSTRACT

BACKGROUND: Gene activation is thought to occur through a series of temporally defined regulatory steps. However, this process has not been completely evaluated in single living mammalian cells. METHODOLOGY/PRINCIPAL FINDINGS: To investigate the timing and coordination of gene activation events, we tracked the recruitment of GCN5 (histone acetyltransferase), RNA polymerase II, Brd2 and Brd4 (acetyl-lysine binding proteins), in relation to a VP16-transcriptional activator, to a transcription site that can be visualized in single living cells. All accumulated rapidly with the VP16 activator as did the transcribed RNA. RNA was also detected at significantly more transcription sites in cells expressing the VP16-activator compared to a p53-activator. After alpha-amanitin pre-treatment, the VP16-activator, GCN5, and Brd2 are still recruited to the transcription site but the chromatin does not decondense. CONCLUSIONS/SIGNIFICANCE: This study demonstrates that a strong activator can rapidly overcome the condensed chromatin structure of an inactive transcription site and supercede the expected requirement for regulatory events to proceed in a temporally defined order. Additionally, activator strength determines the number of cells in which transcription is induced as well as the extent of chromatin decondensation. As chromatin decondensation is significantly reduced after alpha-amanitin pre-treatment, despite the recruitment of transcriptional activation factors, this provides further evidence that transcription drives large-scale chromatin decondensation.


Subject(s)
Chromatin Assembly and Disassembly , Cytological Techniques , Transcriptional Activation/genetics , Alpha-Amanitin/pharmacology , Binding Sites , Cell Cycle Proteins , Cell Line, Tumor , Etoposide/metabolism , Humans , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein Transport , RNA Polymerase II/metabolism , Time Factors , Transcription Factors/metabolism , p300-CBP Transcription Factors/metabolism
4.
Biotechnol Prog ; 23(2): 364-9, 2007.
Article in English | MEDLINE | ID: mdl-17315887

ABSTRACT

Although manipulation of the endoplasmic reticulum (ER) folding environment in the yeast Saccharomyces cerevisiae has been shown to increase the secretory productivity of recombinant proteins, the cellular interactions and processes of native enzymes and chaperones such as protein disulfide isomerase (PDI) are still unclear. Previously, we reported that overexpression of the ER chaperone PDI enabled up to a 3-fold increase in secretion levels of the Pyrococcus furiosus beta-glucosidase in the yeast S. cerevisiae. This result was surprising since beta-glucosidase contains only one cysteine per monomer and no disulfide bonds. Two possible mechanisms were proposed: PDI either forms a transient disulfide bond with the lone cysteine residue of the nascent beta-glucosidase during the folding and assembly process or acts as a chaperone to aid in proper folding. To discern between the two mechanisms, the single cysteine residue was mutated to serine, and the secretion of the two protein variants was determined. The serine mutant still showed increased secretion in vivo when PDI levels were elevated. When the folding bottleneck is removed by increasing expression temperatures to 37 degrees C rather than 30 degrees C, PDI no longer has an improvement on secretion. These results suggest that, unexpectedly, PDI acts in a chaperone-like capacity or possibly cooperates with the cell's folding or degradation mechanisms regardless of whether the protein is redox-active.


Subject(s)
Protein Disulfide-Isomerases/genetics , Protein Disulfide-Isomerases/metabolism , Protein Engineering/methods , Pyrococcus furiosus/physiology , Saccharomyces cerevisiae/physiology , beta-Glucosidase/genetics , beta-Glucosidase/metabolism , Genetic Enhancement/methods , Oxidation-Reduction , Recombinant Proteins/metabolism
5.
Extremophiles ; 11(1): 179-89, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17072686

ABSTRACT

To elucidate determinants of thermostability and folding pathways of the intrinsically stable proteins from extremophilic organisms, we are studying beta-glucosidase from Pyrococcus furiosus. Using fluorescence and circular dichroism spectroscopy, we have characterized the thermostability of beta-glucosidase at 90 degrees C, the lowest temperature where full unfolding is achieved with urea. The chemical denaturation profile reveals that this homotetrameric protein unfolds at 90 degrees C with an overall DeltaG degrees of approximately 20 kcal mol(-1). The high temperatures needed to chemically denature P. furiosus beta-glucosidase and the large DeltaG degrees of unfolding at high temperatures shows this to be one of the most stable proteins yet characterized. Unfolding proceeds via a three-state pathway that includes a stable intermediate species. Stability of the native and intermediate forms is concentration dependent, and we have identified a dimeric assembly intermediate using high temperature native gel electrophoresis. Based on this data, we have developed a model for the denaturation of beta-glucosidase in which the tetramer dissociates to partially folded dimers, followed by the coupled dissociation and denaturation of the dimers to unfolded monomers. The extremely high stability is thus derived from a combination of oligomeric interactions and subunit folding.


Subject(s)
Archaeal Proteins/chemistry , Pyrococcus furiosus/enzymology , beta-Glucosidase/chemistry , Archaeal Proteins/genetics , Archaeal Proteins/metabolism , Circular Dichroism , Cloning, Molecular , Dimerization , Enzyme Stability , Guanidine/chemistry , Models, Molecular , Protein Denaturation , Protein Folding , Protein Structure, Quaternary , Protein Subunits , Recombinant Proteins/chemistry , Spectrometry, Fluorescence , Temperature , Urea/chemistry , beta-Glucosidase/genetics , beta-Glucosidase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...